Table 4.
Multivariate Models of risk factors for 30 days crude mortality in patients population (Forward Stepwise logistic regression)
| OR (CI 95%) | p-value | |
|---|---|---|
| MODEL 1 | ||
| KPC-K.pneumoniae BSI developing during inactive antibiotic treatmenta | 28 (3.9 to 199) | 0.001 |
| Acute myeloid leukemia | Not included in the Model | |
| Shock at onset | Not included in the Model | |
| Intensive chemotherapy | Not included in the model | |
| MODEL 2 | ||
| Initial active treatment | 0.019 (0.002 to 0.20) | 0.001 |
| KPC-K.pneumoniae BSI developing during inactive antibiotic treatmenta | Not included in the model | |
| Acute myeloid leukemia | Not included in the model | |
| Shock at onset | Not included in the model | |
| Intensive chemotherapy | Not included in the model | |
aDeveloping in KPC-K.pneumoniae carriers receiving standard empiric antibiotic treatment